A new recombinant MnSOD prevents the cyclosporine A-induced renal impairment

Nephrology Dialysis Transplantation

Volumn 28, Issue 8, 2013, Pages 2066-2072

  Damiano, Sara ^a   Trepiccione, Francesco ^a   Ciarcia, Roberto ^b   Scanni, Roberto ^a   Spagnuolo, Manuela ^a   Manco, Leonida ^b   Borrelli, Antonella ^c   Capasso, Clemente ^d   Mancini, Roberto ^c   Schiattarella, Antonella ^c   Iervolino, Anna ^a   Zacchia, Enza ^a   Bata Csere, Andrea ^a   Florio, Salvatore ^b   Anastasio, Pietro ^a   Pollastro, Rosamaria ^a   Mancini, Aldo ^c   Capasso, Giovambattista ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

Author keywords

Cyclosporine; Nephrotoxicity; Reactive oxygen species; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; RECOMBINANT MANGANESE SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EFFECT; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; IN VIVO STUDY; MEAN ARTERIAL PRESSURE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

CYCLOSPORINE; NEPHROTOXICITY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

ANIMALS; CYCLOSPORINE; GLOMERULAR FILTRATION RATE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; RENAL INSUFFICIENCY; SUPEROXIDE DISMUTASE;

EID: 84884573113     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft020     Document Type: Article

References (25)

1. Ciresi DL, Lloyd MA, Sandberg SM et al. The sodium retaining effects of cyclosporine. Kidney Int 1992; 41: 1599-1605
2. Parra Cid T, Conejo Garcia F, Carballo A et al. Antioxidant nutrients protect cyclosporine A nephrotoxicity. Toxicology 2003; 189: 99-111
3. Zhong Z, Arteel GE, Connor HD et al. Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 1998; 275: F595-F604
4. Calo LA, Davis PA, Giacon B et al. Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. J Cardiovasc Pharmacol 2002; 40: 625-631
5. 2-formation. Nephrol Dial Transplant 2000; 15: 339-346
6. Diederich D, Skopec J, Diederich A et al. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 1994; 23: 957-961
7. Akira N, Hiroyuki K, Toshiki F et al. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension 2003; 42: 754-760
8. Okado-Matsumoto A, Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver. Cu, Zn-SOD in mitochondria. J Biol Chem 2001; 276: 38388-38393
9. Ridnour LA, Oberley TD, Oberley LW. Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antiox Redox Signal 2004; 6: 501-512
10. Mancini A, Borrelli A, Schiattarella A et al. Tumor suppressive activity of a variant isoform of manganese superoxide dismutase released by a human liposarcoma cell line. Int J Cancer 2006; 119: 932-943
11. Galletti P, Di Gennaro CI, Migliardi V et al. Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. Nephrol Dial Transplant 2005; 20: 1551-1558
12. Capasso G, Di Gennaro C, Della Ragione F et al. In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant 2008; 23: 1186-1195
13. Earle DR, Berliner RW. A simplified clinical procedure for measurement of glomerular filtration rate and renal plasma flow. Proc Soc Exp Biol Med 1946; 62: 262-270
14. Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 1994; 55: 253-258
15. Parra T, de Arriba G, Arribas I et al. Cyclosporine A nephrotoxicity: role of thromboxane and reactive oxygen species. Lab Clin Med 1998; 131: 63-70
16. Wlodarczyk Z, Glyda M, Koscianska L et al. Prevalence of arterial hypertension following kidney transplantation-a mutifactorial analysis. Ann Transplant 2003; 8: 43-46
17. Capasso G, Rosati C, Ciani F et al. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity. Am J Hypertension 1990; 3: 204-210
18. Hoorn EJ, Walsh SB, McCormick JA et al. Pathogenesis of calcineurin inhibitor-induced hypertension. J Nephrol 2012; 25: 269-275
19. Curtis JJ, Luke RG, Jones P et al. Hypertension in cyclosporinetreated renal transplant recipients is sodium dependent. Am J Med 1988; 85: 134-138
20. Esteva-Font C, Ars E, Guillen-Gomez E et al. Ciclosporininduced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2). Nephrol Dial Transplant 2007; 22: 2810-2816
21. Damiano S, Scanni R, Ciarcia R et al. Regulation of sodium transporters in the kidney during cyclosporine treatment. J Nephrol 2010; 16: S191-S198
22. Trepiccione F, Zacchia M, Capasso G. The role of the kidney in salt-sensitive hypertension. Clin Exp Nephrol 2012; 16: 68-72
23. Thomson SC, Tucker BJ, Gabbai F et al. Functional effects on Glomerular hemodynamics of short-term chronic Cyclosporine in Male rats. J Clin Invest 1989; 83: 960-969
24. Zhong Z, Connor HD, Yin M et al. Viral delivery of superoxide dismutase gene reduces cyclosporine A-induced nephrotoxicity. Kidney Int 2001; 59: 1397-404
25. Rosón MI, Della Penna SL, Cao G et al. High-sodium diet promotes a profibrogenic reaction in normal rat kidneys: effects of Tempol administration. J Nephrol 2011; 24: 119-127